|
[1]
|
张勉之, 张敏英, 沈伟梁, 等. 慢性肾功能衰竭原发病的流行病学研究[J]. 中国慢性病预防与控制, 2004, 12(2): 70-72.
|
|
[2]
|
祝全, 赵卫. 尿毒症血透患者眼部与腹主动脉钙化的关系[J]. 西部医学, 2016, 28(2): 204-208.
|
|
[3]
|
Block, G. and Port, F.K. (2003) Calcium Phosphate Metabolism and Cardiovascular Disease in Patients with Chronic Kidney Disease. Seminars in Dialysis, 16, 140-147. [Google Scholar] [CrossRef]
|
|
[4]
|
肖友文, 潘红霞, 鲍永强, 等. 血液透析患者动静脉内瘘血管壁改变与钙磷代谢的相关性研究[J]. 西部医学, 2017, 29(2): 226-230.
|
|
[5]
|
Greenland, P., Bonow, R.O., Brundage, B.H., et al. (2007) ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients with Chest Pain: A Report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circu-lation, 115, 402-426. [Google Scholar] [CrossRef]
|
|
[6]
|
Abd, E.S., Tripepi, G., Mallamaci, F., et al. (2015) Aldosterone, Mortality, Cardiovascular Events and Reverse Epidemiology in End stage Renal Disease. European Journal of Clinical Investigation, 45, 1077-1086. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Mujtaba, M.A., Komocsar, W.J., Nantz, E., et al. (2016) Effect of Treatment with Tabalumab, a B Cel-Activating Factor Inhibitor, on Highly Sensitized Patients with End-Stage Renal Disease Awaiting Transplantation. American Journal of Transplantation, 16, 1266-1275. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Makarovic, S.Z., Makarovic, R., Steiner, et al. (2015) Osteoprotegerin and Vascular Calcification: Clinical and Prognostic Relevance. Collegium Antropologicum, 39, 461-468.
|
|
[9]
|
国家肾脏疾病临床医学研究中心. 中国慢性肾脏病矿物质和骨异常诊治指南概要[J]. 肾脏病与透析肾移植杂志, 2019, 28(1): 52-57.
|
|
[10]
|
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements, 7, 1-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
蔡宏, 严玉澄, 陆任华, 等. 腹主动脉钙化评分可预估血液透析患者的冠状动脉钙化程度[J]. 中国血液净化杂志, 2013, 12(4): 189-194.
|
|
[12]
|
陈澄, 覃春美, 欧三桃, 等. II型糖尿病肾病大鼠肾动脉与肾内小动脉钙化及BMP2和Runx2的表达[J]. 西部医学, 2017, 29(2): 154-159.
|
|
[13]
|
邱翠婷, 吕安林. 维生素K依赖蛋白抑制血管钙化研究进展[J]. 中华临床医师杂志(电子版), 2014, 8(13): 2499-2501.
|
|
[14]
|
Pérez-Hernández, N., Aptilon-Duque, G., Blachman-Braun, R., et al. (2017) Vascular Calcification: Current Genetics Underlying This Complex Phenomenon. Chinese Medical Journal (England), 130, 1113-1121. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
吴雪平, 刘成, 陈卫东. 维持性血液透析患者血管钙化情况横断面调查及其危险因素分析[J]. 齐齐哈尔医学院报, 2020, 7(41): 806-811.
|
|
[16]
|
Shanahan, C.M. (2005) Vascular Calcification. Current Opinion in Nephrology and Hypertension, 14, 361-367. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
徐利鸳, 刘毅, 吴秀娟, 等. 维持性血液透析患者外周血FGF-23水平与血管钙化相关性研究[J]. 中国中西医结合肾病杂志, 2012, 13(4): 323-326.
|
|
[18]
|
韩永魁, 申晓彧. 血管钙化最新相关性研究进展[J]. 中国循证心血管医学杂志, 2020, 12(9): 1144-1146.
|
|
[19]
|
柳诗意, 张宁, 孟祥飞, 等. 补肾活血方通过调节BMP-2/Runx2/Osterix信号通路抑制慢性肾衰竭大鼠血管钙化的实验研究[J]. 中国中西医结合杂志, 2016, 36(3): 327-332.
|
|
[20]
|
周艳, 方炜, 严豪, 等. 炎症、营养不良、瓣膜钙化指标联合预测腹膜透析患者全因死亡和心血管死亡的价值[J]. 上海交通大学学报: 医学版, 2016, 36(9): 1322-1328.
|
|
[21]
|
Rebi, D., Raic, S., Hamzic-Mehmedbaic, A., et al. (2015) Valvular Calcification and Left Ventricular Modifying in Peritoneal Dialysis Patients. Renal Failure, 37, 1316-1322. [Google Scholar] [CrossRef]
|
|
[22]
|
胡绍兰, 杨敏, 白彝华, 等. 营养不良、微炎症状态对腹膜透析患者心血管钙化的影响[J]. 昆明医科大学学报, 2018, 39(7): 47-51.
|
|
[23]
|
Ha, C.M., Park, S., Choi, Y.K., et al. (2014) Activation of Nrf2 by Dimethyl Fumarate Improves Vascular Calcification. Vascular Pharmacology, 63, 29-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chang, J.-R., Sun, N., Liu, Y., et al. (2020) Erythropoietin Attenuates Vascular Calcification by Inhibiting Endoplasmic Reticulum Stress in Rats with Chronic Kidney Disease. Pep-tides, 1, 196-197.
|
|
[25]
|
He, J., Zhong, X.Y., Zhao, L., et al. (2018) JAK2/STAT3/BMP-2 Axis and NF-κB Pathway Are Involved in Erythropoietin-Induced Calcification in Rat Vascular Smooth Muscle Cells. Clinical and Experimental Nephrology, 23, 501-512. [Google Scholar] [CrossRef] [PubMed]
|